Literature DB >> 20417491

Care for women with prior preterm birth.

Jay D Iams1, Vincenzo Berghella.   

Abstract

Women who have delivered an infant between 16 and 36 weeks' gestation have an increased risk of preterm birth in subsequent pregnancies. The risk increases with more than 1 preterm birth and is inversely proportional to the gestational age of the previous preterm birth. African American women have rates of recurrent preterm birth that are nearly twice that of women of other backgrounds. An approximate risk of recurrent preterm birth can be estimated by a comprehensive reproductive history, with emphasis on maternal race, the number and gestational age of prior births, and the sequence of events preceding the index preterm birth. Interventions including smoking cessation, eradication of asymptomatic bacteriuria, progestational agents, and cervical cerclage can reduce the risk of recurrent preterm birth when employed appropriately. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20417491      PMCID: PMC3648852          DOI: 10.1016/j.ajog.2010.02.004

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  109 in total

1.  Periviable birth at 20 to 26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk.

Authors:  Brian Mercer; Cynthia Milluzzi; Marc Collin
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

2.  Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.

Authors:  Catherine Y Spong; Paul J Meis; Elizabeth A Thom; Baha Sibai; Mitchell P Dombrowski; Atef H Moawad; John C Hauth; Jay D Iams; Michael W Varner; Steve N Caritis; Mary J O'Sullivan; Menachem Miodovnik; Kenneth J Leveno; Deborah Conway; Ronald J Wapner; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

3.  Rates of recurrent preterm birth by obstetrical history and cervical length.

Authors:  Celeste P Durnwald; Hetty Walker; Jen C Lundy; Jay D Iams
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

4.  A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.

Authors:  Andrew Shennan; Sarah Crawshaw; Annette Briley; Jenny Hawken; Paul Seed; Griff Jones; Lucilla Poston
Journal:  BJOG       Date:  2006-01       Impact factor: 6.531

Review 5.  Outcomes from assisted reproductive technology.

Authors:  Bradley J Van Voorhis
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

Review 6.  Cyclo-oxygenase (COX) inhibitors for treating preterm labour.

Authors:  J King; V Flenady; S Cole; S Thornton
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 7.  Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data.

Authors:  Vincenzo Berghella; Anthony O Odibo; Meekai S To; Orion A Rust; Sietske M Althuisius
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

8.  Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study.

Authors:  Caroline Moreau; Monique Kaminski; Pierre Yves Ancel; Jean Bouyer; Benoît Escande; Gérard Thiriez; Pierre Boulot; Jeanne Fresson; Catherine Arnaud; Damien Subtil; Loic Marpeau; Jean-Christophe Rozé; Françoise Maillard; Béatrice Larroque
Journal:  BJOG       Date:  2005-04       Impact factor: 6.531

Review 9.  17 hydroxyprogesterone for the prevention of preterm delivery.

Authors:  Paul J Meis
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

Review 10.  Oxytocin receptor antagonists for inhibiting preterm labour.

Authors:  D Papatsonis; V Flenady; S Cole; H Liley
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20
View more
  49 in total

1.  Adverse birth outcomes among nulliparous vs. multiparous women.

Authors:  Marie Lynn Miranda; Sharon E Edwards; Evan R Myers
Journal:  Public Health Rep       Date:  2011 Nov-Dec       Impact factor: 2.792

2.  Injectable silk-based biomaterials for cervical tissue augmentation: an in vitro study.

Authors:  Joseph E Brown; Benjamin P Partlow; Alison M Berman; Michael D House; David L Kaplan
Journal:  Am J Obstet Gynecol       Date:  2015-08-24       Impact factor: 8.661

3.  Acculturation, depressive symptoms, estriol, progesterone, and preterm birth in Hispanic women.

Authors:  R Jeanne Ruiz; C Nathan Marti; Rita Pickler; Christina Murphey; Joel Wommack; Charles E L Brown
Journal:  Arch Womens Ment Health       Date:  2012-01-26       Impact factor: 3.633

Review 4.  17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.

Authors:  Emma D Deeks
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

5.  Development of an ultrasonic method to detect cervical remodeling in vivo in full-term pregnant women.

Authors:  Barbara L McFarlin; Jennifer Balash; Viksit Kumar; Timothy A Bigelow; Xavier Pombar; Jacques S Abramowicz; William D O'Brien
Journal:  Ultrasound Med Biol       Date:  2015-05-23       Impact factor: 2.998

Review 6.  The mechanical role of the cervix in pregnancy.

Authors:  Kristin M Myers; Helen Feltovich; Edoardo Mazza; Joy Vink; Michael Bajka; Ronald J Wapner; Timothy J Hall; Michael House
Journal:  J Biomech       Date:  2015-03-11       Impact factor: 2.712

7.  Differences in risk factors for recurrent versus incident preterm delivery.

Authors:  Katherine L Grantz; Stefanie N Hinkle; Pauline Mendola; Lindsey A Sjaarda; Kira Leishear; Paul S Albert
Journal:  Am J Epidemiol       Date:  2015-06-01       Impact factor: 4.897

8.  Premature delivery and the millennium development goal.

Authors:  Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2012

9.  County-level Variation in Infant Mortality Reporting at Early Previable Gestational Ages.

Authors:  Neera K Goyal; Emily DeFranco; Beena D Kamath-Rayne; Andrew F Beck; Eric S Hall
Journal:  Paediatr Perinat Epidemiol       Date:  2017-07-19       Impact factor: 3.980

10.  Inhibitory effect of progesterone on cervical tissue formation in a three-dimensional culture system with human cervical fibroblasts.

Authors:  Michael House; Serkalem Tadesse-Telila; Errol R Norwitz; Simona Socrate; David L Kaplan
Journal:  Biol Reprod       Date:  2014-01-30       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.